Zymergen Inc. (ZY) 은(는) 상장 기업입니다 기초소재 섹터의 Chemicals - Specialty 산업에서 운영. 본사 소재지는 EmeryVille, CA, 미국. 현재 CEO는 Joshua J. Hoffmann.
ZY 을(를) 보유 IPO 날짜 2021-04-22, 502 명의 정규직 직원, 에 상장 NASDAQ Global Select.
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.
